Eli Lilly and Company, which manufactures one of the new weight-loss drugs, has launched an advertising campaign reinforcing that the drugs should not be used for cosmetic weight loss.
ABIM faces backlash as internists rebel against costly, time-consuming MOC exam. Can longitudinal assessments offer a smoother path to board certification?